Geron Corp (GERN) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts GERN Hot Sheet
Price: $1.57 --0%
Financial Fact:
Interest and other income: 293K
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Interest and other income: 293K
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Geron Corp (NASDAQ: GERN) reported Q2 EPS of ($0.17), in-line with the analyst estimate of ($0.17). Revenue for the quarter came in at $462 thousand versus the consensus estimate of $1.37 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Birkenstock Holding (BIRK) Misses Q3 EPS by 2c; lifts guidance
- Bragg Gaming Group Inc. (BRAG) Tops Q2 EPS by 2c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
